Hochstenbach R, van Gijn M E, Krijtenburg P-J, Raemakers R, van 't Slot R, Renkens I, Eleveld M J, van der Smagt J J, Poot M
Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
Mol Syndromol. 2013 Jan;3(6):274-83. doi: 10.1159/000345241. Epub 2012 Nov 20.
In a 24-year-old man with mild intellectual disability, congenital heart defects and obesity, we identified up to 4 small supernumerary marker chromosomes (sSMCs) in blood metaphases. The ring-shaped sSMCs were derived from chromosomes 11, 12 and X as well as a fourth, unidentified chromosome. In interphase nuclei of epithelial cells from the urinary tract and buccal mucosa, the presence of the r(11), r(12) and r(X) was confirmed by FISH. Using Illumina Infinium 317K SNP-arrays, we detected 3 copies of the pericentromeric regions of chromosomes 11, 12 and X. The r(X) was present in 84-89% of cells in the various tissues examined, lacks the XIST gene, but contains FAM123B, a potential dosage-sensitive candidate gene for congenital cardiac abnormalities, and ARHGEF9, a candidate gene for intellectual disability. ARHGEF9 encodes collybistin (CB), which is required for localization of the inhibitory receptor-anchoring protein gephyrin and for formation and maintenance of postsynaptic GABAA and glycine receptors. We propose that the 2-fold increase in dosage of ARHGEF9 disturbs the stoichiometry of CB with its interacting proteins at inhibitory postsynapses. SNP alleles and short tandem repeat markers on the r(11) and r(X) were compatible with a maternal origin of both sSMCs through a meiosis II error. The sSMCs may have resulted from predivision chromatid nondisjunction, leading to anaphase lagging, followed by incomplete degradation of the supernumerary chromosomes.
在一名患有轻度智力残疾、先天性心脏缺陷和肥胖症的24岁男性中,我们在血液中期相中鉴定出多达4条小的额外标记染色体(sSMC)。这些环状sSMC分别来源于11号、12号染色体和X染色体,以及第四条未鉴定的染色体。通过荧光原位杂交(FISH)在来自尿路和颊黏膜的上皮细胞间期核中证实了r(11)、r(12)和r(X)的存在。使用Illumina Infinium 317K SNP阵列,我们检测到11号、12号染色体和X染色体着丝粒周围区域有3个拷贝。r(X)存在于所检查的各种组织中84 - 89%的细胞中,缺乏XIST基因,但包含FAM123B,这是一个可能对先天性心脏异常具有剂量敏感性的候选基因,以及ARHGEF9,一个与智力残疾相关的候选基因。ARHGEF9编码collybistin(CB),它是抑制性受体锚定蛋白gephyrin定位以及突触后GABAA和甘氨酸受体形成和维持所必需的。我们认为ARHGEF9剂量增加2倍会扰乱CB与其在抑制性突触处相互作用蛋白的化学计量。r(11)和r(X)上的SNP等位基因和短串联重复标记与这两条sSMC均通过减数分裂II错误来自母体起源相符。这些sSMC可能是由于染色单体预分离不分离导致后期落后,随后额外染色体不完全降解所致。